# STOCKHOLM 1.0
#=GF ID   PTB
#=GF AC   PF08416.17
#=GF DE   Phosphotyrosine-binding domain
#=GF AU   Wuster A;0000-0003-4162-5931
#=GF SE   Pfam-B_3174 (release 18.0)
#=GF GA   27.00 27.00;
#=GF TC   27.00 27.00;
#=GF NC   26.90 26.90;
#=GF BM   hmmbuild HMM.ann SEED.ann
#=GF SM   hmmsearch --cpu 4 -Z 75585367 -E 1000 HMM pfamseq
#=GF TP   Domain
#=GF WK   Phosphotyrosine-binding_domain
#=GF CL   CL0266
#=GF RN   [1]
#=GF RM   11023826
#=GF RT   Molecular characterization of human tensin. 
#=GF RA   Chen H, Ishii A, Wong WK, Chen LB, Lo SH; 
#=GF RL   Biochem J 2000;351:403-411.
#=GF RN   [2]
#=GF RM   14592531
#=GF RT   Tensin. 
#=GF RA   Lo SH; 
#=GF RL   Int J Biochem Cell Biol 2004;36:31-34.
#=GF DR   INTERPRO; IPR013625;
#=GF DR   SO; 0000417; polypeptide_domain;
#=GF CC   The phosphotyrosine-binding domain (PTB, also
#=GF CC   phosphotyrosine-interaction or PI domain) in the protein tensin
#=GF CC   tends to be found at the C-terminus.  Tensin is a multi-domain
#=GF CC   protein that binds to actin filaments and functions as a
#=GF CC   focal-adhesion molecule (focal adhesions are regions of plasma
#=GF CC   membrane through which cells attach to the extracellular
#=GF CC   matrix).  Human tensin has actin-binding sites, an SH2
#=GF CC   (Pfam:PF00017) domain and a region similar to the tumour
#=GF CC   suppressor PTEN [1].  The PTB domain interacts with the
#=GF CC   cytoplasmic tails of beta integrin by binding to an NPXY motif
#=GF CC   [2].
#=GF SQ   10
#=GS EPS8_MOUSE/64-194        AC Q08509.2
#=GS A0A0R4IID9_DANRE/51-181  AC A0A0R4IID9.2
#=GS G5E5T1_BOVIN/51-181      AC G5E5T1.2
#=GS ES8L1_HUMAN/35-165       AC Q8TE68.3
#=GS F1N4S3_BOVIN/28-157      AC F1N4S3.3
#=GS H3DAX3_TETNG/54-181      AC H3DAX3.1
#=GS F6YU93_MACMU/1269-1403   AC F6YU93.3
#=GS Q9VHC3_DROME/580-716     AC Q9VHC3.1
#=GS TENS3_HUMAN/1310-1444    AC Q68CZ2.2
#=GS Q0P4Q6_XENTR/61-191      AC Q0P4Q6.1
EPS8_MOUSE/64-194                   QYRVEHLTTFVLDRKDAMITVEDGIRKLKLLDAKGKVWTQDMILQVDDRAVSLIDLESKNEL.ENFPLNTISHCQAVVHACSYDS........ILALVCKEPTQSKPDL.HLFQCDEVK...ANLISEDIESAISDSKGGKQKR
A0A0R4IID9_DANRE/51-181             QYHVEHLTTFVMDRKEAMLTIEDGIRKLRLLDAKGKIWTQDMLLQVDNRAVSLIDHDSKNEL.ENFPLGSIQHCQPVTNACSYDS........ILALVCKESGQGKPDL.HLFQCEDIK...ASLIHMDIESAISDHKGGKIKK
G5E5T1_BOVIN/51-181                 QYHVQHLATFIMDKSEAITSVEDAIRKLVQLSSKEKIWTQEMLLQVNDQSLRLLDMESQEEL.ENFPLPSVRHSQTVLNQLRYPS........VLLLVCQDADQSKPDV.HFFHCDEVE...AELVQEDIESALADCRLGKKMR
ES8L1_HUMAN/35-165                  QYPVNHLVTFCLGEDDGVHTVEDASRKLAVMDSQGRVWAQEMLLRVSPDHVTLLDPASKEEL.ESYPLGAIVRCDAVMPPGRSRS........LLLLVCQEPERAQPDV.HFFQGLRLG...AELIREDIQGALHNYRSGRGER
F1N4S3_BOVIN/28-157                 QHRVEHLMTCKLGTQR.IQEPKDALQKLQEMDAQGRVWSQDLLLQVRDGWLQLLDIETKEEL.ESYRLDRIKVMDVALNTGSYNS........VLSITVQDSDLRSTST.LLFQCQEVG...AERLKTSLEKALEEEVEQRPQL
H3DAX3_TETNG/54-181                 QYRVEHLFTFELDGRQ.LRNVSDCVEQLQLLEEMGRVWGQSMLLQVQPPRLLLTDIETKMEL.ESVAIGDVLEVKAVLDSGPFNS........LLTVSVQTRRRGSTSI.FVFQ.SDIRVSAADLIQRDLSRAL....LNKPKT
F6YU93_MACMU/1269-1403              ACSVLYLTSVETESLTGPQAVAR..ASSAALSCSPRPTPAVVHFKVSAQGITLTDNQRKLFFRRHYPVNSITFSSTDPQDRRWTNPDG.TTSKIFGFVAKKPGSPWENVCHLFA..ELD...PDQPAGAIVTFITKVLLGQ.RK
Q9VHC3_DROME/580-716                ATNVLWLYSCDTESLTGNEAIRK..AIRQMYGQQPLPQPTEVHFKVSSQGITLTDNTRKKFFRKHYKADVISHCAIDPENRMWTSEGESDKKTIFAFVARRSHSSTDNQCHVFC..DLS...VSQPAAAIVSFANRTLPTEKLR
TENS3_HUMAN/1310-1444               ACNVWYLNSVEMESLTGHQAIQK..ALSITLVQEPPPVSTVVHFKVSAQGITLTDNQRKLFFRRHYPVNSVIFCALDPQDRKWIKDGP..SSKVFGFVARKQGSATDNVCHLFA..EHD...PEQPASAIVNFVSKVMIGSPKK
Q0P4Q6_XENTR/61-191                 QYHIEHLTTFVMDRKDGVLTVDDGIRKLKLLDAKGKVWTQDMLLQVDDKGVSLYDVDTKSEL.ENFPLSSVQHCQAVMNACRYDS........ILALVCKEPAQSKADL.HLFQCDEIK...ASLVQRDIDSAISDSKGGKQKK
#=GC seq_cons                       QY+VpHLsTFph-ppcuhpsVcDulcKLphL-upG+lWoQ-MLLQVsspuloLhDh-oKpEL.EsaPLsoIp+CpsVhssspasS........lLulVs+-sspupssl.HLFQspElc...A-LlppDIpoAlscshhG+.++
